Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Katie Palmer Aging Research Center, Division of Geriatric
Epidemiology and Medicine, Neurotec, Karolinska Institute, and
Stockholm Gerontology Research Center, Box 6401, 11382, Stockholm,
Sweden
Correspondence to: K Palmer
katie.palmer{at}neurotec.ki.se
Objectives:
To evaluate a simple three step procedure to identify people in the general population who are in the preclinical phase of Alzheimer's disease and dementia.
What is already known on this topic
Elderly people with subjective memory complaints and objective global
cognitive impairment have a high risk of developing Alzheimer's
disease and dementia What this study adds
However, only 18% of people in the preclinical phase can be identified
using this procedure About half of the people in the preclinical phase of Alzheimer's
disease and dementia do not report problems with their memory three
years before diagnosis
Design:
Three year population based cohort study.
Setting:
Kungsholmen cohort, Stockholm, Sweden.
Participants:
1435 people aged 75-95 years without dementia.
Assessments:
Single question asking about memory
complaints, assessment by mini-mental state examination, and
neuropsychological testing.
Main outcome measure:
Alzheimer's disease and
dementia at three year follow up.
Results:
None of the three instruments was
sufficiently predictive of Alzheimer's disease and dementia when
administered separately. After participants had been screened for
memory complaints and global cognitive impairment, specific tests of
word recall and verbal fluency had positive predictive values for
dementia of 85-100% (95% confidence intervals range from 62% to
100%). However, only 18% of future dementia cases were identified in the preclinical phase by this three step procedure. Memory complaints were the most sensitive indicator of Alzheimer's disease and dementia in the whole population, but only half the future dementia cases reported memory problems three years before diagnosis.
Conclusion:
This three step procedure, which
simulates what might occur in clinical practice, has a high positive
predictive value for dementia, although only a small number of future
cases can be identified.
Alzheimer's disease is characterised by a preclinical phase, during
which cognitive deficits are seen before diagnosis
This three step procedure (self report of memory complaints, test of
global cognitive functioning, and then domain specific cognitive tests)
has a positive predictivity of 85-100% for Alzheimer's disease and
dementia at three years
© 2003 BMJ Publishing Group Ltd
Read all Rapid Responses